Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Real-time quantitative PCR analysis of human CD14+ monocytes during the confinement within the Eskiz experiment

ABSTRACT: Human CD14 positive monocytes were purified from healthy volunteers' blood

ORGANISM(S): Homo sapiens

PROVIDER: GSE196510 | GEO | 2022/02/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Real-time quantitative PCR analysis of human CD14+ monocytes during the confinement within the Eskiz experiment

Project description:Real-time quantitative PCR analysis of human CD14+ monocytes during the confinement within the Eskiz experiment

| PRJNA805225 | ENA

Real-time quantitative PCR analysis of human dendritic cells

Project description:Human CD14 positive monocytes were purified from healthy volunteers' blood and were differentiated to immature dendritic cells in vitro by culturing for five days in the presence of interleukin-4 (IL-4 100 ng/ml) and GM-CSF (75 ng/ml). Immature dendritic cells were activated three different ways for 24 hours: 1. Double-stranded DNA poly(dA:dT) (2.5 μg/ml) complexed with LyoVec transfection reagent. 2. LPS (500 ng/ml) 3. Inflammatory cocktail containing 10 ng/ml TNF, 5 ng/ml IL-1β, 20 ng/ml IL-6, 75 ng/ml GM-CSF and 1 μg/ml PGE2. We used SA Biosciences Antigen Presenting and Toll-like Receptor Pathway PCR Arrays to quantitate gene expression of immunologically relevant genes from the immature and the differently activated cells. Monocytes from three donors were used and treated separately as indicated in the summary. Equal amount total RNA from each donor was pooled prior to gene expression analysis.

2011-05-08 | E-GEOD-29131 | biostudies-arrayexpress

Real-time quantitative PCR analysis of monocytes of major depressed patients [Venlafaxin study]

Project description:Human CD14 positive monocytes were purified from major depressed patients or healthy volunteer frozen PBMC. Patients were treated with venlafaxine. Responders and non-responders to venlafaxine were recorded after 6 weeks of treatment

2019-06-07 | GSE132312 | GEO

Real-time quantitative PCR analysis of monocytes of major depressed patients [Imipramine study]

Project description:Human CD14 positive monocytes were purified from major depressed patients or healthy volunteer frozen PBMC. Patients were treated with imipramin. Responders and non-responders to imipramin were recorded after 6 weeks of treatment

2019-06-07 | GSE132310 | GEO

Real-time quantitative PCR analysis of human dendritic cells

2011-05-08 | GSE29131 | GEO

Real-time quantitative PCR analysis of monocytes of major depressed patients [Sertraline study]

Project description:Human CD14 positive monocytes were purified from major depressed patients or healthy volunteer frozen PBMC. Patients were treated with Sertralin or Sertralin + Celecoxib. Responders and non-responders to Sertralin and Sertralin + Celecoxib were recorded after 6 weeks of treatment

2019-06-07 | GSE132314 | GEO

SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset

Project description:Monocytes are a heterogeneous cell population with subset-specific functions and phenotypes. The differential expression of CD14 and CD16 distinguishes classical CD14++CD16-, intermediate CD14++CD16+ and non-classical CD14+CD16++ monocytes. However, CD14++CD16+ monocytes remain the most poorly characterized subset so far. Therefore we analyzed the transcriptomes of the three monocyte subsets using SuperSAGE in combination with high-throughput sequencing. Analysis of 5,487,603 tags revealed unique identifiers of CD14++CD16+ monocytes, delineating these cells from the two other monocyte subsets. CD14++CD16+ monocytes were linked to antigen processing and presentation (e.g. CD74, HLA-DR, IFI30, CTSB), to inflammation and monocyte activation (e.g. TGFB1, AIF1, PTPN6), and to angiogenesis (e.g. TIE2, CD105). Therefore we provide genetic evidence for a distinct role of CD14++CD16+ monocytes in human immunity. Human monocyte subsets (CD14++CD16-, CD14++CD16+, CD14+CD16++) were isolated from 12 healthy volunteers based on MACS technology. Total RNA from monocyte subsets was isolated and same aliquots from each donor and monocyte subset were matched for SuperSAGE. Three SuperSAGE libraries (CD14++CD16-, CD14++CD16+ and CD14+CD16++) were generated.

2011-07-24 | E-GEOD-30811 | biostudies-arrayexpress

TaqMan Human miRNA array profile of CD14++CD16- and CD14+CD16++ monocyte subsets

Project description:Human Freshly isolated monocyte (CD14++CD16-) and (CD14+ CD16++) were purified from healthy volunteers' blood, and sorted by FAC. We used Taqman miRNA TLDA arrays to performed miRNA profiling

2020-04-10 | GSE137730 | GEO

Real-time quantitative PCR analysis of human T cells

Project description:Human peripheral blood mononuclear cells were purified from healthy volunteers' blood and were cultured in the presence of the monoclonal antibody OKT3 or a recombinant fragment of humanized anti-CD3. After 72 hours, CD3+ T cells were isolated by negative selection using beads.

2016-11-30 | GSE88820 | GEO

Baseline expression of lymphatic and inflammatory genes in CD14+ blood monocytes from healthy donors

Project description:Blood was donated by four healthy volunteers with no known illness or malignancies. Mononuclear cells were separated from the blood by density gradient and CD14+ cells were isolated using anti-CD14 IgG-conjugated magnetic beads and magnetic separation (Miltenyi Biotec). We used an in-house array to analyze the gene expression of a total of 270 targets including 67 cytokines, 57 cytokine receptors, 18 chemokines, 11 chemokines receptors, 10 known TLR4 downstream targets, 64 other inflammation-related proteins, 12 genes expressed primarily in lymphatic endothelial cells, and 32 endothelial cell associated proteins. The results show a baseline expression in CD14+ PBMC in healthy individuals which can be used to detect changes in CD14+ PBMC population via transcript expression in individuals with illnesses and malignancies such as breast cancer.

2016-04-22 | GSE75518 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data